Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721343 · ClinicalTrials.gov registry record · NA
Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 516
- Enrollment target
NCT01721343: Completed NA study, sponsored by Mayo Clinic.
NCT01721343 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 516 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01721343, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 516 participants
- Enrollment target
Study Summary
This randomized clinical trial studies collaborative targeted case management in improving functional status in patients with stage III-IV cancer. Collaborative targeted case management may improve functional mobility, improve quality of life, and reduce pain and health care utilization in patients with advanced cancer
Primary Outcome
The mean change in the Ambulatory Post-Acute Care Basic Mobility Computer Adaptive Test (AM PAC CAT) score (month 6 minus baseline) and the \[95% confidence interval\] for patients assigned to each arm regardless of compliance are reported below. The AM PAC CAT is an item response theory-modeled scale that ranges from 0 to infinity. However, the score range of interest for the trial that corresponds to the ability to ambulate and transfer safely and independently (+/- gait aid) is 55 - 66 with h
Interventions
- OTHER questionnaire administration
- PROCEDURE management of therapy complications
- BEHAVIORAL telephone-based intervention
- PROCEDURE physical therapy
- OTHER case management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2012-11-07 |
| Est. Completion | 2019-08-03 |
| Phase | NA |
What the finished NCT01721343 record still lists
NCT01721343 is an interventional study that assigns participants to a tested intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01721343 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01721343 about?
NCT01721343 is a clinical study titled "Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer". This randomized clinical trial studies collaborative targeted case management in improving functional status in patients with stage III-IV cancer. Collaborative targeted case management may improve functional mobility, improve quality of life, and reduce pain and health care utilization in patients ...
What is the current status of trial NCT01721343?
This trial is currently completed. It is a NA study. The enrollment target is 516 participants. The study started on 2012-11-07. Estimated completion is 2019-08-03.
What interventions are being tested in trial NCT01721343?
The interventions under investigation include: questionnaire administration (OTHER), management of therapy complications (PROCEDURE), telephone-based intervention (BEHAVIORAL), physical therapy (PROCEDURE), case management (OTHER).
Who is sponsoring clinical trial NCT01721343?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01721343's enrollment target sits among peer trials
516 191st of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05933083 · 516 participants · NA
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- NCT06804837 · 515 participants · NA
Implement and Test Visual Consent Template and Process
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI